Next Article in Journal
Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases
Next Article in Special Issue
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
Previous Article in Journal
Comparison of Wealth-Related Inequality in Tetanus Vaccination Coverage before and during Pregnancy: A Cross-Sectional Analysis of 72 Low- and Middle-Income Countries
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 432; https://doi.org/10.3390/vaccines12040432
Action Date Notes Link
article pdf uploaded. 17 April 2024 16:44 CEST Version of Record https://www.mdpi.com/2076-393X/12/4/432/pdf-vor
article supplementary file uploaded. 17 April 2024 16:44 CEST - https://www.mdpi.com/2076-393X/12/4/432#supplementary
article xml file uploaded 18 April 2024 06:34 CEST Original file -
article xml uploaded. 18 April 2024 06:34 CEST Update https://www.mdpi.com/2076-393X/12/4/432/xml
article pdf uploaded. 18 April 2024 06:34 CEST Updated version of record https://www.mdpi.com/2076-393X/12/4/432/pdf
article html file updated 18 April 2024 06:35 CEST Original file https://www.mdpi.com/2076-393X/12/4/432/html
Back to TopTop